Australasian Sarcoma Study Group (ASSG) is engaged in providing a range of pharmaceutical research services. It is principally involved in conducting research activities that address sarcoma and related tumors. ASSG operates as a collaborative research unit of 70 clinicians. It involves in national and international basic, clinical, translational, and supportive care research studies. ASSG works in close association with Cancer Australia and Clinical Oncological Society of Australia. Currently, it is working on cancer clinical research program in collaboration with the University of Melbourne and Australian Government. Further, it offers infrastructure for collaboration between multi-disciplinary teams (MDT) that serve specialized cases. ASSG is headquartered in Melbourne, Victoria, Australia.

Street: 
Peter MacCallum Cancer Centre
City: 
Melbourne
Postcode: 
8006
Federal State : 
Australia
WebSite: 
www.australiansarcomagroup.org

Company Index Score

Current Index Score Historical Index Score
  • Australasian Sarcoma Study Group currently scores 50 % in the index.
  • Australasian Sarcoma Study Group is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Australasian Sarcoma Study Group is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets